Concepedia
Publication | Open Access
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes
91
Citations
33
References
2019
Year
The Trial Registration Number was NCT00854399.
Page 1